Efficacy of three drugs agomelatine, bupropion and sertraline in the treatment of major depressive disorder

Phase 3

Recruiting

• Conditions: Major depressive disorder.; Major depressive disorder, single episode, mild; F32.0

• Registration Number: IRCT20190525043700N4
• Lead Sponsor: Babol University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 1 November 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

Age 20-60 years
Major Depressive Disorder (Based on the diagnosis of a psychiatrist and a psychiatric assistant with a structured clinical interview based on the DSM-5)

Exclusion Criteria

Drug abuse
Hypothyroidism
Severe anemia
Pregnancy and lactation
Epilepsy
Mental retardation

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Patient´s depressive condition. Timepoint: Before the intervention (first visit), end of the second week (second visit), end of the fourth week (third visit), end of the eighth week (fourth visit). Method of measurement: Hamilton Questionnaire.